Worldwide Clinical Trials (Worldwide) is a global CRO serving development-driven biopharmaceutical companies, with more than 4,400 professionals operating across more than 70 countries. The company delivers therapeutically dedicated expertise in neuroscience, oncology, rare disease, and internal medicine, with comprehensive support across every development phase – from early-stage and first-in-human studies through Phase III registration trials. The company's flexible service model – spanning full-service trial management to functional service partnerships through Worldwide Flex – is powered by a people first, partnership driven outsourcing approach that strengthens collaboration, enhances data transparency, and supports more informed decision making. This provides sponsors with tailored, adaptable solutions that keep pace with the evolving demands of clinical research. Learn more at www.worldwide.com
Looking for a particular Worldwide Clinical Trials employee's phone or email?
The Worldwide Clinical Trials annual revenue was $634 million in 2026.
David Bowser is the COO of Worldwide Clinical Trials.
3,031 people are employed at Worldwide Clinical Trials.
The NAICS codes for Worldwide Clinical Trials are [621, 325, 32, 62, 62151, 6215, 3254].
The SIC codes for Worldwide Clinical Trials are [28, 283].